Background Peritoneal tumor dissemination arising from colorectal cancer, appendiceal
cancer, gastric cancer, gynecologic malignancies or peritoneal mesothelioma is a common sign …

Pseudomyxoma Peritonei (PMP) is a rare peritoneal malignancy, most commonly originating
from a perforated epithelial tumour of the appendix. Given its rarity, randomized controlled …

Tumor involvement of the peritoneum—peritoneal carcinomatosis—is a heterogeneous form
of cancer that had been generally regarded as a sign of systemic tumor disease and as a …

Purpose : Pseudomyxoma peritonei (PMP) originating from an appendiceal mucinous
neoplasm remains a biologically heterogeneous disease. The purpose of our study was to …

… Chua, Pompiliu Piso, and Paul H. Sugarbaker … Morris, Pompiliu Piso, Paul H.
Sugarbaker … Chua, Pompiliu Piso, Perry Shen, Paul H. Sugarbaker Data analysis and …

Background. Recent reports suggest that mesenchymal stem cells (MSCs) have immunomodulatory
properties. Mesenchymal stem cells can suppress the immune response toward …

Background & Aims: Prognostication in colon cancer almost exclusively still rests on the
tumor stage. Furthermore, tumor-derived markers to improve discrimination of low- and high-risk …

BACKGROUND: Currently, no tumor‐node‐metastasis (TNM) staging system exists for
patients with diffuse malignant peritoneal mesothelioma (DMPM). The primary objective was to …

Purpose: Inhibitors of heat-shock protein 90 (Hsp90) may interfere with oncogenic signaling
pathways, including Erk, Akt, and hypoxia-inducible factor-1α (HIF-1α). Because insulin-like …

Background Enhanced recovery after surgery (ERAS) pathways have been shown to
considerably reduce complications, length of stay and costs after most of surgical procedures by …